Cranberry Pomace Extract Exerts Antiviral Activity against Zika and Dengue Virus at Safe Doses for Adult Zebrafish - Université de La Réunion Access content directly
Journal Articles Viruses Year : 2022

Cranberry Pomace Extract Exerts Antiviral Activity against Zika and Dengue Virus at Safe Doses for Adult Zebrafish

Abstract

Mosquito-borne dengue virus (DENV) and zika virus (ZIKV) infections constitute a global health emergency. Antivirals directly targeting the virus infectious cycle are still needed to prevent dengue hemorrhagic fever and congenital zika syndrome. In the present study, we demonstrated that Cranberry Pomace (CP) extract, a polyphenol-rich agrifood byproduct recovered following cranberry juice extraction, blocks DENV and ZIKV infection in human Huh7.5 and A549 cell lines, respectively, in non-cytotoxic concentrations. Our virological assays identified CP extract as a potential inhibitor of virus entry into the host-cell by acting directly on viral particles, thus preventing their attachment to the cell surface. At effective antiviral doses, CP extract proved safe and tolerable in a zebrafish model. In conclusion, polyphenol-rich agrifood byproducts such as berry extracts are a promising source of safe and naturally derived nutraceutical antivirals that target medically important pathogens.
Fichier principal
Vignette du fichier
viruses-14-01101-v2.pdf (2.27 Mo) Télécharger le fichier
Origin Publication funded by an institution
Licence

Dates and versions

hal-04227799 , version 1 (04-10-2023)

Licence

Identifiers

Cite

Laura Tamkutė, Juliano G Haddad, Nicolas Diotel, Philippe Desprès, Petras Rimantas Venskutonis, et al.. Cranberry Pomace Extract Exerts Antiviral Activity against Zika and Dengue Virus at Safe Doses for Adult Zebrafish. Viruses, 2022, 14 (5), pp.1101. ⟨10.3390/v14051101⟩. ⟨hal-04227799⟩
50 View
34 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More